Search

everythinglearnresearchcommunity

for

Search:↓

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Isotretinoin was not effective in treating facial lichen planopilaris.

A rare ovarian tumor can cause unusual male-like symptoms, but surgery usually leads to a good outcome.

Diagnosing Sertoli-Leydig cell tumors is challenging due to their unusual symptoms and can occur at any age.

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

A woman was diagnosed with a rare adrenal gland cancer that did not show usual hormone-related symptoms.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

The most common skin problems in perimenopausal women in South India are infections, eczemas, and acne, possibly worsened by external factors and lifestyle practices.

The higher dose supplement was more effective in treating female hair loss.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Hair loss can be treated with medications like minoxidil and finasteride or surgery, but treatment effectiveness varies by alopecia type and accurate diagnosis is important.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Woman with diabetes had hair loss due to rare ovarian tumor; surgery improved hair growth.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Hormone therapy for trans individuals is effective and generally safe in the short term.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.